company background image
543321 logo

Tatva Chintan Pharma Chem BSE:543321 Stock Report

Last Price

₹1.08k

Market Cap

₹25.2b

7D

-7.3%

1Y

-34.0%

Updated

28 Mar, 2024

Data

Company Financials +

Tatva Chintan Pharma Chem Limited

BSE:543321 Stock Report

Market Cap: ₹25.2b

543321 Stock Overview

Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India.

543321 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends1/6

Tatva Chintan Pharma Chem Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tatva Chintan Pharma Chem
Historical stock prices
Current Share Price₹1,079.55
52 Week High₹1,888.05
52 Week Low₹1,063.35
Beta-0.084
1 Month Change-13.20%
3 Month Change-32.63%
1 Year Change-34.01%
3 Year Changen/a
5 Year Changen/a
Change since IPO-53.27%

Recent News & Updates

Recent updates

Shareholder Returns

543321IN ChemicalsIN Market
7D-7.3%2.2%2.5%
1Y-34.0%20.6%47.3%

Return vs Industry: 543321 underperformed the Indian Chemicals industry which returned 20.6% over the past year.

Return vs Market: 543321 underperformed the Indian Market which returned 47.3% over the past year.

Price Volatility

Is 543321's price volatile compared to industry and market?
543321 volatility
543321 Average Weekly Movement3.6%
Chemicals Industry Average Movement6.0%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 543321's share price has been volatile over the past 3 months.

Volatility Over Time: 543321's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996608Chintan Shahhttps://www.tatvachintan.com

Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals.

Tatva Chintan Pharma Chem Limited Fundamentals Summary

How do Tatva Chintan Pharma Chem's earnings and revenue compare to its market cap?
543321 fundamental statistics
Market cap₹25.23b
Earnings (TTM)₹376.99m
Revenue (TTM)₹4.20b

66.9x

P/E Ratio

6.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
543321 income statement (TTM)
Revenue₹4.20b
Cost of Revenue₹2.14b
Gross Profit₹2.05b
Other Expenses₹1.68b
Earnings₹376.99m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)16.12
Gross Margin48.95%
Net Profit Margin8.98%
Debt/Equity Ratio8.4%

How did 543321 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

10%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.